Showing 21 - 40 results of 497 for search '"Фармакоэкономика"', query time: 0.04s Refine Results
  1. 21
    REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS

    REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS by Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev

    Published 2015-09-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 22
    Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis

    Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis by N. Yu. Nikolenko, D. А. Kudlay, N. P. Doktorova

    Published 2021-07-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 23
    Biophysical modeling indicates a high affinity of ethyl esters of omega-3 polyunsaturated fatty acids to the enzymes of the pro-inflammatory arachidonic acid cascade

    Biophysical modeling indicates a high affinity of ethyl esters of omega-3 polyunsaturated fatty acids to the enzymes of the pro-inflammatory arachidonic acid cascade by I. Yu. Torshin, O. A. Gromova

    Published 2022-07-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 24
    Long-term analysis of сanagliflozin budget impact in adult patients with type 2 diabetes mellitus and diabetic nephropathy in the Russian Federation

    Long-term analysis of сanagliflozin budget impact in adult patients with type 2 diabetes mellitus and diabetic nephropathy in the Russian Federation by N. A. Avxentyev, Yu. V. Makarova

    Published 2022-10-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 25
    Study of the effect of human placenta hydrolysate in a new model of metabolic-associated fatty liver disease with iron overload

    Study of the effect of human placenta hydrolysate in a new model of metabolic-associated fatty liver disease with iron overload by T. E. Bogacheva, O. A. Gromova, I. Yu. Torshin, V. I. Demidov, A. G. Kalacheva, A. A. Garanin, I. V. Gogoleva, L. E. Fedotova, O. A. Limanova, А. N. Mnatsakanyan, N. Yu. Zhidomorov, T. R. Grishina

    Published 2025-02-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 26
    Providing pharmaceutical consultation to visitors of pharmacy organizations in routine pharmaceutical practice

    Providing pharmaceutical consultation to visitors of pharmacy organizations in routine pharmaceutical practice by M. S. Soboleva

    Published 2023-07-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 27
    PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT

    PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT by N. K. Mazina, P. V. Mazin, Yu. V. Kislitsin, E. M. Markova

    Published 2016-04-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 28
    Analysis of social and economic aspects of using prolonged forms of opioid analgesics for the treatment of chronic pain syndrome in cancer patients

    Analysis of social and economic aspects of using prolonged forms of opioid analgesics for the treatment of chronic pain syndrome in cancer patients by E. A. Pyadushkina, E. V. Derkach, A. V. Palekhov

    Published 2023-07-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 29
    IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM?

    IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM? by V. V. Omelyanovskiy

    Published 2015-05-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 30
    UN MILLENNIUM DEVELOPMENT GOALS INDICATORS ON PROBLEMS OF ACCESS TO ESSENTIAL MEDICINES AND ENHANCEMENT OF LOCAL PHARMACEUTICAL PRODUCER IN DEVELOPING COUNTRIES

    UN MILLENNIUM DEVELOPMENT GOALS INDICATORS ON PROBLEMS OF ACCESS TO ESSENTIAL MEDICINES AND ENHANCEMENT OF LOCAL PHARMACEUTICAL PRODUCER IN DEVELOPING COUNTRIES by A. Y. Kulikov, A. G. Voskanyan

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 31
    The influence of the combination of methanolic extract <i>Scurrula atropurpurea</i> (Blume) and <i>Dendrophthoe pentandra</i> on rat liver function and structure

    The influence of the combination of methanolic extract <i>Scurrula atropurpurea</i> (Blume) and <i>Dendrophthoe pentandra</i> on rat liver function and structure by N. Athiroh, N. J. Mubarakati, Yu. Purnomo

    Published 2024-11-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 32
    Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025

    Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical... by V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova

    Published 2023-07-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 33
    Analysis of acquisition and the monthly cost of antihypertensive therapy with modern fixed-dose combinations in the Far Eastern Federal District

    Analysis of acquisition and the monthly cost of antihypertensive therapy with modern fixed-dose combinations in the Far Eastern Federal District by M. S. Soboleva, E. E. Loskutova

    Published 2021-04-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 34
    METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY

    METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY by N. A. Avxentyev, E. V. Derkach, E. A. Pyadushkina, M. D. Ter-Ovanesov

    Published 2016-09-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 35
    EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS

    EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS by N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova

    Published 2016-12-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 36
    ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION

    ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION by M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 37
    Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia

    Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia by I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina

    Published 2018-05-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 38
    Experience of using telemedicine technologies in healthcare systems of foreign countries and the Russian Federation: systematic review

    Experience of using telemedicine technologies in healthcare systems of foreign countries and the Russian Federation: systematic review by O. A. Volkova, S. S. Budarin, E. V. Smirnova, Yu. V. Elbek

    Published 2022-01-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 39
    Economic burden of chronic viral hepatitis C

    Economic burden of chronic viral hepatitis C by R. A. Yakhina, I. A. Lakman, D. A. Valishin, R. Kh. Bakhitova

    Published 2022-01-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 40
    Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital

    Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital by L. N. Sheikhmambetova, E. A. Egorova, K. N. Onishchenko, E. I. Konyaeva

    Published 2021-10-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: